{"id":"https://openalex.org/W4401280730","doi":"https://doi.org/10.1016/j.jconrel.2024.07.062","title":"The safety of recombinant human hyaluronidase PH20 in nonclinical models: An overview of toxicology, pharmacology, and impact of anti-PH20 antibodies","display_name":"The safety of recombinant human hyaluronidase PH20 in nonclinical models: An overview of toxicology, pharmacology, and impact of anti-PH20 antibodies","publication_year":2024,"publication_date":"2024-08-24","ids":{"openalex":"https://openalex.org/W4401280730","doi":"https://doi.org/10.1016/j.jconrel.2024.07.062","pmid":"https://pubmed.ncbi.nlm.nih.gov/39089505"},"language":"en","primary_location":{"id":"doi:10.1016/j.jconrel.2024.07.062","doi":"https://doi.org/10.1016/j.jconrel.2024.07.062","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2024.07.062","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019134345","display_name":"Ryan P. Nolan","orcid":"https://orcid.org/0009-0006-6298-7754","observed_orcids":["https://orcid.org/0009-0006-6298-7754","https://orcid.org/0009-0007-0433-826X"]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan P. Nolan","raw_affiliation_strings":["Halozyme Therapeutics, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Halozyme Therapeutics, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101648599","display_name":"David W. Kang","orcid":"https://orcid.org/0000-0002-2653-468X","observed_orcids":["https://orcid.org/0000-0002-2653-468X"]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David W. Kang","raw_affiliation_strings":["Halozyme Therapeutics, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Halozyme Therapeutics, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036585443","display_name":"Daniel C. Maneval","orcid":"https://orcid.org/0000-0002-8143-9992","observed_orcids":["https://orcid.org/0000-0002-8143-9992"]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel C. Maneval","raw_affiliation_strings":["Formerly with Halozyme Therapeutics, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Formerly with Halozyme Therapeutics, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000012602","display_name":"Stephen P Knowles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen P. Knowles","raw_affiliation_strings":["Formerly with Halozyme Therapeutics, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Formerly with Halozyme Therapeutics, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005466184","display_name":"Michael J. LaBarre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. LaBarre","raw_affiliation_strings":["Halozyme Therapeutics, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Halozyme Therapeutics, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003607591","display_name":"Marie A. Printz","orcid":"https://orcid.org/0009-0007-0222-367X","observed_orcids":["https://orcid.org/0009-0007-0222-367X"]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marie A. Printz","raw_affiliation_strings":["Halozyme Therapeutics, Inc., San Diego, CA, USA. Electronic address: mprintz@halozyme.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Halozyme Therapeutics, Inc., San Diego, CA, USA. Electronic address: mprintz@halozyme.com","institution_ids":["https://openalex.org/I4210088034"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5003607591"],"corresponding_institution_ids":["https://openalex.org/I4210088034"],"apc_list":{"value":4540,"currency":"USD","value_usd":4540},"apc_paid":null,"fwci":0.7116,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.59497601,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"374","issue":null,"first_page":"369","last_page":"383"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.8359000086784363,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.03610000014305115,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8529999852180481},{"id":"https://openalex.org/keywords/hyaluronan-depolymerization","display_name":"hyaluronan depolymerization","score":0.9350000023841858},{"id":"https://openalex.org/keywords/subcutaneous-drug-delivery","display_name":"subcutaneous drug delivery","score":0.9409999847412109},{"id":"https://openalex.org/keywords/fertility","display_name":"fertility","score":0.5419999957084656},{"id":"https://openalex.org/keywords/sperm-motility","display_name":"sperm motility","score":0.7039999961853027},{"id":"https://openalex.org/keywords/fetal-development","display_name":"fetal development","score":0.8330000042915344},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.5540000200271606},{"id":"https://openalex.org/keywords/pharmacology","display_name":"pharmacology","score":0.6259999871253967},{"id":"https://openalex.org/keywords/hyaluronidase","display_name":"hyaluronidase","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5284286141395569},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4373672306537628},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41799819469451904},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3649901747703552},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.337063729763031},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16583478450775146},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006820","descriptor_name":"Hyaluronic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006821","descriptor_name":"Hyaluronoglucosaminidase","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006821","descriptor_name":"Hyaluronoglucosaminidase","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006821","descriptor_name":"Hyaluronoglucosaminidase","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015815","descriptor_name":"Cell Adhesion Molecules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jconrel.2024.07.062","doi":"https://doi.org/10.1016/j.jconrel.2024.07.062","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2024.07.062","pdf_url":null,"source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},{"id":"pmid:39089505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39089505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of controlled release : official journal of the Controlled Release Society","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1655974874","https://openalex.org/W1747924952","https://openalex.org/W1828970458","https://openalex.org/W1906683030","https://openalex.org/W1965410604","https://openalex.org/W1978261191","https://openalex.org/W1993808853","https://openalex.org/W2005061722","https://openalex.org/W2011560862","https://openalex.org/W2018796671","https://openalex.org/W2019763836","https://openalex.org/W2025122282","https://openalex.org/W2034076854","https://openalex.org/W2036497724","https://openalex.org/W2036788483","https://openalex.org/W2044401681","https://openalex.org/W2045546162","https://openalex.org/W2060682538","https://openalex.org/W2064337645","https://openalex.org/W2069345108","https://openalex.org/W2107881500","https://openalex.org/W2110427985","https://openalex.org/W2128466784","https://openalex.org/W2154774450","https://openalex.org/W2158548553","https://openalex.org/W2163054595","https://openalex.org/W2315129148","https://openalex.org/W2419131886","https://openalex.org/W2472310215","https://openalex.org/W2790654944","https://openalex.org/W2883052264","https://openalex.org/W2905700230","https://openalex.org/W2912407716","https://openalex.org/W3078996272","https://openalex.org/W3120453637","https://openalex.org/W3186523768","https://openalex.org/W3203868108","https://openalex.org/W4224236087","https://openalex.org/W4302219957","https://openalex.org/W4306940470","https://openalex.org/W4386704767"],"related_works":["https://openalex.org/W3203868108","https://openalex.org/W3078996272","https://openalex.org/W1655974874","https://openalex.org/W7097204575","https://openalex.org/W2898179167","https://openalex.org/W4306940470","https://openalex.org/W3118573022","https://openalex.org/W7148384611","https://openalex.org/W3186523768","https://openalex.org/W2912407716"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2024-08-03T00:00:00"}